289 related articles for article (PubMed ID: 10815923)
1. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
2. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen JG; Horwitz SB
Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
[TBL] [Abstract][Full Text] [Related]
3. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
4. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
5. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G
Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345
[TBL] [Abstract][Full Text] [Related]
6. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
7. A common pharmacophore for cytotoxic natural products that stabilize microtubules.
Ojima I; Chakravarty S; Inoue T; Lin S; He L; Horwitz SB; Kuduk SD; Danishefsky SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4256-61. PubMed ID: 10200249
[TBL] [Abstract][Full Text] [Related]
8. Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy.
Giannakakou P; Fojo T
Clin Cancer Res; 2000 May; 6(5):1613-5. PubMed ID: 10815877
[No Abstract] [Full Text] [Related]
9. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
11. The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies.
Martello LA; LaMarche MJ; He L; Beauchamp TJ; Smith AB; Horwitz SB
Chem Biol; 2001 Sep; 8(9):843-55. PubMed ID: 11564553
[TBL] [Abstract][Full Text] [Related]
12. (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest.
Hung DT; Chen J; Schreiber SL
Chem Biol; 1996 Apr; 3(4):287-93. PubMed ID: 8807856
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity.
Isbrucker RA; Gunasekera SP; Longley RE
Cancer Chemother Pharmacol; 2001 Jul; 48(1):29-36. PubMed ID: 11488521
[TBL] [Abstract][Full Text] [Related]
14. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.
Klein LE; Freeze BS; Smith AB; Horwitz SB
Cell Cycle; 2005 Mar; 4(3):501-7. PubMed ID: 15711127
[TBL] [Abstract][Full Text] [Related]
15. Tumor-killer made; how does it work?
Service RF
Science; 1996 Dec; 274(5295):2009. PubMed ID: 8984658
[No Abstract] [Full Text] [Related]
16. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice.
Huang GS; Lopez-Barcons L; Freeze BS; Smith AB; Goldberg GL; Horwitz SB; McDaid HM
Clin Cancer Res; 2006 Jan; 12(1):298-304. PubMed ID: 16397055
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines.
McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ
Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947
[TBL] [Abstract][Full Text] [Related]
19. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
20. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
